IBDEI1WK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31864,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31864,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,31864,1,3,0)
 ;;=3^Paliperidone Palmitate Extend Release 117mg/kit
 ;;^UTILITY(U,$J,358.3,31865,0)
 ;;=J2426^^139^1471^5^^^^1
 ;;^UTILITY(U,$J,358.3,31865,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31865,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,31865,1,3,0)
 ;;=3^Paliperidone Palmitate Extend Release 78mg/kit
 ;;^UTILITY(U,$J,358.3,31866,0)
 ;;=J2426^^139^1471^4^^^^1
 ;;^UTILITY(U,$J,358.3,31866,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31866,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,31866,1,3,0)
 ;;=3^Paliperidone Palmitate Extend Release 39mg/kit
 ;;^UTILITY(U,$J,358.3,31867,0)
 ;;=J2794^^139^1471^12^^^^1
 ;;^UTILITY(U,$J,358.3,31867,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31867,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,31867,1,3,0)
 ;;=3^Risperidone Long Act 50mg/vial
 ;;^UTILITY(U,$J,358.3,31868,0)
 ;;=J2794^^139^1471^10^^^^1
 ;;^UTILITY(U,$J,358.3,31868,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31868,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,31868,1,3,0)
 ;;=3^Risperidone Long Act 25mg/vial
 ;;^UTILITY(U,$J,358.3,31869,0)
 ;;=J2794^^139^1471^11^^^^1
 ;;^UTILITY(U,$J,358.3,31869,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31869,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,31869,1,3,0)
 ;;=3^Risperidone Long Act 37.5mg/vial
 ;;^UTILITY(U,$J,358.3,31870,0)
 ;;=J2794^^139^1471^9^^^^1
 ;;^UTILITY(U,$J,358.3,31870,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31870,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,31870,1,3,0)
 ;;=3^Risperidone Long Act 12.5mg/vial
 ;;^UTILITY(U,$J,358.3,31871,0)
 ;;=J2315^^139^1471^13^^^^1
 ;;^UTILITY(U,$J,358.3,31871,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31871,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,31871,1,3,0)
 ;;=3^Vivitrol 1mg
 ;;^UTILITY(U,$J,358.3,31872,0)
 ;;=96150^^139^1472^1^^^^1
 ;;^UTILITY(U,$J,358.3,31872,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31872,1,2,0)
 ;;=2^96150
 ;;^UTILITY(U,$J,358.3,31872,1,3,0)
 ;;=3^Behavior/Health Init Assm,Ea 15min
 ;;^UTILITY(U,$J,358.3,31873,0)
 ;;=96151^^139^1472^2^^^^1
 ;;^UTILITY(U,$J,358.3,31873,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31873,1,2,0)
 ;;=2^96151
 ;;^UTILITY(U,$J,358.3,31873,1,3,0)
 ;;=3^Behavior/Health Re-Assm,Ea 15min
 ;;^UTILITY(U,$J,358.3,31874,0)
 ;;=99211^^140^1473^1
 ;;^UTILITY(U,$J,358.3,31874,1,0)
 ;;=^358.31IA^1^1
 ;;^UTILITY(U,$J,358.3,31874,1,1,0)
 ;;=1^Nursing Only Visit
 ;;^UTILITY(U,$J,358.3,31875,0)
 ;;=T74.11XA^^141^1474^8
 ;;^UTILITY(U,$J,358.3,31875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31875,1,3,0)
 ;;=3^Spouse/Partner or Nonspouse/Nonpartner Violence,Physical,Confirmed,Initial Encounter
 ;;^UTILITY(U,$J,358.3,31875,1,4,0)
 ;;=4^T74.11XA
 ;;^UTILITY(U,$J,358.3,31875,2)
 ;;=^5054146
 ;;^UTILITY(U,$J,358.3,31876,0)
 ;;=T74.11XD^^141^1474^9
 ;;^UTILITY(U,$J,358.3,31876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31876,1,3,0)
 ;;=3^Spouse/Partner or Nonspouse/Nonpartner Violence,Physical,Confirmed,Subsequent Encounter
 ;;^UTILITY(U,$J,358.3,31876,1,4,0)
 ;;=4^T74.11XD
 ;;^UTILITY(U,$J,358.3,31876,2)
 ;;=^5054147
 ;;^UTILITY(U,$J,358.3,31877,0)
 ;;=T76.11XA^^141^1474^10
 ;;^UTILITY(U,$J,358.3,31877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31877,1,3,0)
 ;;=3^Spouse/Partner or Nonspouse/Nonpartner Violence,Physical,Suspected,Initial Encounter
 ;;^UTILITY(U,$J,358.3,31877,1,4,0)
 ;;=4^T76.11XA
 ;;^UTILITY(U,$J,358.3,31877,2)
 ;;=^5054221
 ;;^UTILITY(U,$J,358.3,31878,0)
 ;;=T76.11XD^^141^1474^11
 ;;^UTILITY(U,$J,358.3,31878,1,0)
 ;;=^358.31IA^4^2
